Study reveals systemic underdiagnosis and undertreatment of homozygous familial hypercholesterolemia

by

A new study from the Family Heart Foundation shows the diagnosis and treatment of homozygous familial hypercholesterolemia (HoFH) is delayed, and often occurs after a heart attack or early atherosclerotic cardiovascular disease (ASCVD).

Leave A Comment

Your email address will not be published. Required fields are marked *